

Since 2018, the emergence of multidrug-resistant Vibrio cholerae strains in eastern Africa has raised serious public health concerns due to the potential loss of effective treatment options.1–3 Recently, concurrent cholera outbreaks among travellers from Germany and the UK returning from Ethiopia as well as among residents were traced to a sacred fountain contaminated with a highly drug-resistant V cholerae O1 strain. Whole-genome sequencing and comparative genomics of V cholerae isolates from both patients and water samples confirmed the fountain as the source of infection, and antimicrobial susceptibility testing showed a multidrug-resistant phenotype.
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet